drugset / Trial / NCT01033825
Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To demonstrate the effects of ciclesonide applied as a nasal aerosol and ciclesonide aqueous (AQ) nasal spray on hypothalamic-pituitary-adrenal axis.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ciclesonide | Other / unclassified | 160 ug | Intranasal |
| Subject | Ciclesonide | Other / unclassified | 200 ug | Intranasal |
| Subject | Ciclesonide | Other / unclassified | 320 ug | Intranasal |
| Comparator | Dexamethasone | Small molecule | 6 mg | Oral |